213 related articles for article (PubMed ID: 34284551)
1. DIC, SIC or CAC - the haemostatic profile in COVID-19 patients hospitalised in the intensive care unit: a single-centre retrospective analysis.
Pluta J; Pihowicz A; Horban A; Trzebicki J
Anaesthesiol Intensive Ther; 2021; 53(2):108-114. PubMed ID: 34284551
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study.
Ding R; Wang Z; Lin Y; Liu B; Zhang Z; Ma X
Blood Coagul Fibrinolysis; 2018 Sep; 29(6):551-558. PubMed ID: 30015646
[TBL] [Abstract][Full Text] [Related]
3. External Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis.
Yamakawa K; Yoshimura J; Ito T; Hayakawa M; Hamasaki T; Fujimi S
Thromb Haemost; 2019 Feb; 119(2):203-212. PubMed ID: 30593085
[TBL] [Abstract][Full Text] [Related]
4. Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.
Iba T; Arakawa M; Di Nisio M; Gando S; Anan H; Sato K; Ueki Y; Levy JH; Thachil J
J Intensive Care Med; 2020 Jul; 35(7):643-649. PubMed ID: 29720054
[TBL] [Abstract][Full Text] [Related]
5. The unique characteristics of COVID-19 coagulopathy.
Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
[TBL] [Abstract][Full Text] [Related]
6. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
7. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
Ibañez C; Perdomo J; Calvo A; Ferrando C; Reverter JC; Tassies D; Blasi A
J Thromb Thrombolysis; 2021 Feb; 51(2):308-312. PubMed ID: 32671609
[TBL] [Abstract][Full Text] [Related]
8. Coagulopathy in COVID-19.
Iba T; Levy JH; Levi M; Thachil J
J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
[TBL] [Abstract][Full Text] [Related]
9. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of soluble fibrin monomer complex in patients in SARS-CoV-2 COVID-19 infection-associated coagulopathy.
Sridharan M; D Navitskas S; M Kock E; E Houghton D; M Heikal N; Chen D; K Pruthi R
Eur J Haematol; 2022 Apr; 108(4):319-326. PubMed ID: 34921683
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review.
Mori H; Ohkawara H; Togawa R; Rikimaru M; Shibata Y; Ikezoe T
Int J Hematol; 2021 Mar; 113(3):320-329. PubMed ID: 33550533
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study.
Luan YY; Liu Y; Liu XY; Yu BJ; Chen RL; Peng M; Ren D; Li HL; Huang L; Liu Y; Li JX; Feng YW; Wu M
Thromb Res; 2020 Nov; 195():62-68. PubMed ID: 32659462
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients.
Soundar EP; Jariwala P; Nguyen TC; Eldin KW; Teruya J
Am J Clin Pathol; 2013 Jun; 139(6):812-6. PubMed ID: 23690126
[TBL] [Abstract][Full Text] [Related]
15. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.
Hoechter DJ; Becker-Pennrich A; Langrehr J; Bruegel M; Zwissler B; Schaefer S; Spannagl M; Hinske LC; Zoller M
Thromb Res; 2020 Dec; 196():186-192. PubMed ID: 32891904
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Sepsis-Induced Coagulopathy in Critically Ill Pediatric Patients with Septic Shock.
Jhang WK; Park SJ
Thromb Haemost; 2021 Apr; 121(4):457-463. PubMed ID: 33124023
[TBL] [Abstract][Full Text] [Related]
18. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Intravascular Coagulation Score and Sepsis-induced Coagulopathy Score in Prediction of COVID-19 Severity: A Retrospective Analysis.
Kapoor M; Panda PK; Saini LK; Bahurupi Y
Indian J Crit Care Med; 2021 Dec; 25(12):1357-1363. PubMed ID: 35027794
[TBL] [Abstract][Full Text] [Related]
20. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
